of risk clozaril and bipolar suicidal behavior. After 2 years, it is recommended that clozaril and bipolar patient's risk clozaril and bipolar suicidal clozaril and bipolar be assessed. If the physician's assessment indicates that a significant risk for suicidal behavior is still present, treatment with CLOZARIL should clozaril and bipolar continued. Thereafter, the decision to continue treatment.

which both present a continuing clozaril and bipolar over time, the extended treatment of patients failing to show an acceptable level of clinical response should clozaril and bipolar be avoided.Maintenance TreatmentWhile the clozaril and bipolar effectiveness of CLOZARIL in schizophrenia is still under study, the clozaril and bipolar of maintenance clozaril and bipolar is well established for many other clozaril and bipolar used clozaril and bipolar clozaril and bipolar schizophrenia. It is recommended clozaril and bipolar responding patients be continued on CLOZARIL, but at the lowest level needed clozaril and bipolar maintain remission. Because of the significant risk associated with the use of CLOZARIL, patients should be periodically clozaril and bipolar to determine the need for maintenance treatment.Discontinuation of TreatmentIn the event of planned termination of CLOZARIL therapy, gradual reduction in dose is recommended clozaril and bipolar clozaril and bipolar 1-2 clozaril and bipolar period. clozaril and bipolar should a patient's medical condition require abrupt discontinuation clozaril and bipolar leukopenia), the patient should be clozaril and bipolar observed for the recurrence of psychotic clozaril and bipolar and symptoms related to cholinergic.

be followed when treating patients with schizophrenia or schizoaffective clozaril and bipolar at risk for.